Adebowale J. Adeniran, MD

Articles by Adebowale J. Adeniran, MD

The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy

ByKaren Malkhasyan, MD,Hari A. Deshpande, MD,Adebowale J. Adeniran, MD,John W. Colberg, MD,Daniel P. Petrylak, MD

October 15th 2013

A 55-year-old woman with a history of metastatic melanoma in remission for 8 years presented to the emergency department with gross hematuria. A CT scan, ordered because the patient was in menopause, demonstrated a bladder tumor.

Latest Updated Articles

The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy
October 15th 2013

Adebowale J. Adeniran, MD

Articles by Adebowale J. Adeniran, MD

The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy

Latest Updated Articles

Trending on CancerNetwork

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma

Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors

Daraxonrasib Shows Antitumor Activity in Pretreated RAS+ Pancreatic Cancer

Selecting Among Preferred 1L Regimens — A Discussion